Case Study: YourChoice Therapeutics

Pioneering a hormone-free future in male contraception, YourChoice Therapeutics worked with Quotient Sciences to conduct a Phase 1a clinical trial of its therapy.

For more than six decades, innovation in contraception has remained largely unchanged. Research shows that most men and women view contraception as a shared responsibility, but the lack of male-specific options means the burden continues to fall on women.

Download a copy of our "Pioneering a hormone-free future in male contraception" case study/